TLR7 and COVID-19: Furthermore, reduction of E2-2 expression upon TLR7 stimulation, as mentioned above for pDC exhaustion in other viral infections [17], is a likely mechanism driving pDC hypo-functionality in COVID-19 patients, although E2-2 levels have not been studied in pDC from SARS-CoV-2 infected cohorts.